Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification - Quercioli, A; Luciano Viviani, G; Dallegri, F (Crit Pathw Cardiol, 2010)
et al.